KalVista Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending July 31, 2024 was 46.2M shares, a 34.3% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 36.8M shares, a 31.9% increase from 2022.
  • KalVista Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 27.9M shares, a 14% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 24.5M shares, a 28.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 46.2M +11.8M +34.3% May 1, 2024 Jul 31, 2024 10-Q 2024-09-05
Q1 2024 36.8M +8.9M +31.9% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-11
Q4 2023 34.7M +6.44M +22.8% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 34.6M +9.97M +40.5% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-07
Q2 2023 34.4M +9.86M +40.1% May 1, 2023 Jul 31, 2023 10-Q 2024-09-05
Q1 2023 27.9M +3.42M +14% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-11
Q4 2022 28.3M +3.8M +15.5% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
Q3 2022 24.6M +155K +0.64% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-07
Q2 2022 24.6M +128K +0.52% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q1 2022 24.5M Feb 1, 2022 Apr 30, 2022 10-K 2024-07-11
Q4 2021 24.5M Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-09
Q3 2021 24.4M Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-08
Q2 2021 24.4M May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.